Biosci Biotechnol Biochem. 2026 Apr 21:zbag054.doi: 10.1093/bbb/zbag054.

中文速读

研究吡非尼酮通过PLK1信号调控淋巴管生成抑制肺癌转移的机制,但未使用Engreen产品。

小鼠肺HMVEC-LLy

本文使用:RNA体内转染Entranster™-in vivo

查看产品详情(含全部 502 篇文献) →

Effect of pirfenidone on the regulation of lymph angiogenesis by PLK1 signaling to inhibit metastasis of lung cancer in vivo

Affiliations

Affiliations

  • 1 Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Hangzhou Normal University.
  • 2 Clinical Medical College, Hangzhou Normal University.

Abstract

This study investigated the mechanism of pirfenidone (PFD) inhibiting metastasis of lung cancer in vivo.A nude mouse lung cancer model was established and treated with PFD (200, 400 μg/mL); lung metastatic tumor weight was recorded, Lyve-1 (lymphatic marker), LC3II (autophagy protein) and polo-like kinase 1 (PLK1) were detected. In human lung lymphatic endothelial cells (HMVEC-LLy) cells, PFD’s effects on migration, apoptosis, lymphangiogenesis, and LC3II/LC3I/PLK1 levels were tested. PLK1-overexpressed HMVEC-LLy cells were treated with 400 μg/mL PFD to explore its mechanism. PFD inhibited the weight of lung metastases and down-regulated the expression levels of Lyve-1, LC3II/LC3I and PLK1. In cell experiments, PFD was found to inhibit HMVEC-LLy migration, apoptosis and lymph angiogenesis, as well as down-regulate LC3II/LC3I and PLK1 protein levels, and these effects could be reversed by PLK1 overexpression.PFD may inhibit lung cancer metastasis in vivo by regulating lymph angiogenesis through PLK1 signaling.

Keywords: autophagy; lung cancer; lymph angiogenesis; pirfenidone; polo-like kinase 1.

本文使用的产品

RNA体内转染Entranster™-in vivo

已有 502 篇已发表文献

查看产品详情(含全部 502 篇文献) →

热线电话
  • 010-60535354
微信客服二维码 微信扫一扫,加微信客服
0
0
我的购物车
购物车是空的去下单